Abstract:The pH‐sensitive imidazolyl ionizable lipids are designed and synthesized for siRNA delivery. LNPs formulated with the best‐performing lipid (O12‐D3‐I3) induce greater gene silencing efficiency due to their stronger endosomal escape. In addition, O‐LNP loaded with ferroptosis associated siRNA stimulates long‐lasting and effective ferroptosis through synergistic action in vivo, with significant anti‐tumor effects. Treatments for cancer that incorporate small interfering RNA (siRNA) to target iron‐dependent ferroptosis are thought to be highly promising. However, creating a reliable and clinically feasible siRNA delivery system continues to be a major obstacle in the field of cancer treatment. Here, three imidazole‐based ionizable lipid nanoparticles (LNPs) with pH‐sensitive effects are rationally designed and synthesized for siRNA delivery. LNPs formulated with the top‐performing lipid (O12‐D3‐I3) encapsulating FVII siRNA (FVII@O‐LNP) elicited greater gene silencing than those with the benchmark Onpattro lipid DLin‐MC3‐DMA (MC3) due to its stronger endosomal escape. Moreover, Fc‐siRNA@O‐LNPs encapsulated with ferrocene (Fc) and SLC7A11/Nrf2‐targeted siRNA is formulated. The outcomes demonstrate optimal safety profiles and a significant anti‐tumor effect by inducing long‐lasting and efficient ferroptosis through a synergistic action in vivo. In summary, this work shows that imidazolyl lipid‐prepared LNPs are efficient delivery vehicles for cancer therapy and ferroptosis‐targeting siRNA administration, both of which have extensive clinical application potential.

Rational design of engineered H-ferritin nanoparticles with improved siRNA delivery efficacy across an in vitro model of the mouse BBB

A novel polyethyleneimine-decorated FeOOH nanoparticle for efficient siRNA delivery

Rational Engineering of a Designed Protein Cage for siRNA Delivery.

RNA-binding peptide and endosomal escape-assisting peptide (L2) improved siRNA delivery by the hexahistidine–metal assembly

A Novel Form of Arginine-Chitosan as Nanoparticles Efficient for siRNA Delivery into Mouse Leukemia Cells

Tetrahedral DNA Framework‐Based Spherical Nucleic Acids for Efficient siRNA Delivery

Engineered human H -chain ferritin with reversed charge of internal cavity exhibits RNA-mediated sponge-like effect for loading of RNA/DNA binding molecules

Smart Nanoparticles Assembled by Endogenous Molecules for Sirna Delivery and Cancer Therapy Via CD44 and EGFR Dual-Targeting

Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy

Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissues

Electrostatic Interactions‐Independent Approach for Efficient siRNA Encapsulation with Stimuli‐Responsive Charge Reversal and Controlled Release

Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer

Liquid crystalline inverted lipid phases encapsulating siRNA enhance lipid nanoparticle mediated transfection

Unlocking the Treasure Box: The Role of HEPES Buffer in Disassembling an Uncommon Ferritin Nanoparticle

Silica Nanoparticles with Virus-Mimetic Spikes Enable Efficient siRNA Delivery In Vitro and In Vivo

AIE Featured Inorganic-Organic Core@Shell Nanoparticles for High-Efficiency Sirna Delivery and Real-Time Monitoring

Preparation and brain targeting effects study of recombinant human ferritin nanoparticles

Efficient Cytosolic Delivery Of Sirna Using Hdl-Mimicking Nanoparticles

Efficient Systemic Delivery Of Sirna By Using High-Density Lipoprotein-Mimicking Peptide Lipid Nanoparticles

Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization

A Neutralized Noncharged Polyethylenimine-Based System for Efficient Delivery of Sirna into Heart Without Toxicity.